Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
1998 • 2,916 citations
DNA Vaccines: Immunology, Application, and Optimization
2000 • 1,212 citations
T-cell apoptosis detected in situ during positive and negative selection in the thymus
1994 • 1,071 citations
High-efficiency gene transfer into skeletal muscle mediated by electric pulses
1999 • 901 citations
gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand
1998 • 490 citations
Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma
1997 • 405 citations
Fundamentals of electroporative delivery of drugs and genes
1999 • 393 citations
High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
1999 • 388 citations
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy
1996 • 289 citations
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens
1996 • 250 citations
Coupling and Uncoupling of Tumor Immunity and Autoimmunity
1999 • 245 citations
Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle.
1996 • 222 citations
An autologous oral DNA vaccine protects against murine melanoma
2000 • 161 citations
Development of Cancer Immunotherapies Based on Identification of the Genes Encoding Cancer Regression Antigens
1996 • 132 citations
The immunogenicity of single and combination DNA vaccines against tuberculosis
2000 • 128 citations
Genetic vaccination with 'self' tyrosinase-related protein 2 causes melanoma eradication but not vitiligo
2000 • 116 citations
Tumor antigens recognized by cytolytic T lymphocytes: Present perspectives for specific immunotherapy
1993 • 109 citations
Bleomycin-Mediated Electrochemotherapy of Metastatic Melanoma
1996 • 108 citations
Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.
1998 • 78 citations
Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice
1999 • 72 citations
Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity
1999 • 66 citations
Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes
2000 • 64 citations
Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8+ and CD4+ T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity
1999 • 61 citations
Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3
2000 • 54 citations